Results 91 to 100 of about 11,901 (167)

Malaria Screening and Treatment in Hematopoietic Cell Transplant Donors and Sickle Cell Disease Candidates/Recipients: A Case Series Using Malaria Polymerase Chain Reaction Testing and a Literature Review

Transplant Infectious Disease, Volume 28, Issue 1, January/February 2026.
Malaria polymerase chain reaction (PCR) testing is more sensitive than conventional diagnostics. Routine PCR screening of at‐risk asymptomatic hematopoietic cell donors and transplant candidates may prevent unnecessary deferrals or treatment. In our experience, PCR negativity during screening or after treatment supports donor/candidate eligibility ...
Mary M. Czech, Sanchita Das, Emily Limerick, Courtney Fitzhugh, Matthew Hsieh, Jennifer Cuellar‐Rodriguez   +5 more
wiley   +1 more source

Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana

Malaria Journal, 2012
Background In Guyana, chloroquine + primaquine is used for the treatment of vivax malaria. A worldwide increase of chloroquine resistance in Plasmodium vivax led to questioning of the current malaria treatment guidelines. A therapeutic efficacy study was
Eibach Daniel, Ceron Nicolas, Krishnalall Karanchand, Carter Keith, Bonnot Guillaume, Bienvenu Anne-Lise, Picot Stéphane   +6 more
doaj   +1 more source

Molecular Markers of Antimalarial Drug Resistance in Plasmodium falciparum From Kumasi, Ghana, 2023

Tropical Medicine &International Health, Volume 31, Issue 1, Page 43-48, January 2026.
ABSTRACT Objectives Artemisinin partial resistance has emerged in East Africa and is feared to spread across the continent, potentially compromising artemisinin‐based combination treatment. Molecular markers can serve as early warning signals for the development of specific drug resistance.
Albert Dennis Kegya, Elizabeth Oppong, Eric Darko, Kwame Ayisi Boateng, Richard Odame Phillips, Melina Heinemann, Michael Ramharter, Clement Igiraneza, Jules Minega Ndoli, Frank P. Mockenhaupt, Welmoed van Loon   +10 more
wiley   +1 more source

Artemether-Lumefantrine Treatment Failure despite adequate lumefantrine day 7 Concentration in a Traveller with Plasmodium Falciparum Malaria after Returning from Tanzania. [PDF]

Artemether-lumefantrine is currently first-line therapy of Plasmodium falciparum malaria in many countries. This report describes a treatment failure despite adequate drug concentrations in a traveller returning from sub-Saharan Africa.
Färnert, Anna, Karlsson, Lillemor, Tolfvenstam, Thomas, Lindegårdh, Niklas, Ursing, Johan, Sparrelid, Elda, Rono, Josea   +6 more
core  

Severe Plasmodium knowlesi Malaria in a Tertiary Care Hospital, Sabah, Malaysia

Emerging Infectious Diseases, 2011
The simian parasite Plasmodium knowlesi causes severe human malaria; the optimal treatment remains unknown. We describe the clinical features, disease spectrum, and response to antimalarial chemotherapy, including artemether-lumefantrine and artesunate ...
Timothy William, Jayaram Menon, Giri S. Rajahram, Leslie Chan, Gordon Ma, Samantha Donaldson, Serena Khoo, Charlie Fredrick, Jenarun Jelip, Nicholas M. Anstey, Tsin Wen Yeo   +10 more
doaj   +1 more source

Tablet Manipulation Practices Among Community Pharmacy Clients in Ghana: A Cross‐Sectional Survey

Advances in Public Health, Volume 2026, Issue 1, 2026.
Background Tablets are preferred dosage forms due to their accurate dosing, stability, and easy handling and administration. Oral tablets are sometimes manipulated via splitting or crushing before intake for dose flexibility and other reasons to meet specific needs.
Hilda Amekyeh, Salifu Nanga, Doris Kumadoh, Osei-Asibey Antwi, Charles Amoako, Augustine Bekoe, Gifty Dede Tsewayo, Wendy Armah, Frederick William Akuffo Owusu, Francis Brako, Donatus Wewura Adongo, Hannah Wesley   +11 more
wiley   +1 more source

Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. [PDF]

, 2008
BACKGROUND: Combination antimalarial therapy is recommended for the treatment of uncomplicated falciparum malaria in Africa; however, some concerns about the safety and tolerability of new regimens remain.
Njama-Meya Denise, Staedke Sarah G, Catherine Maiteki-Sebuguzi, Denise Njama-Meya, Moses R Kamya, Sarah G Staedke, Maiteki-Sebuguzi Catherine, Grant Dorsey, Yau, Vincent M, Jagannathan, Prasanna, Dorsey, Grant, Talisuna, Ambrose O, Dorsey Grant, Ambrose O Talisuna, Rosenthal Philip J, Jagannathan Prasanna, Maiteki-Sebuguzi, Catherine, Rosenthal, Philip J, Tamara D Clark, Clark Tamara D, Nzarubara Bridget, Staedke, Sarah G, Prasanna Jagannathan, Yau Vincent M, Nzarubara, Bridget, Vincent M Yau, Philip J Rosenthal, Njama-Meya, Denise, Clark, Tamara D, Kamya Moses R, Bridget Nzarubara, Kamya, Moses R, Talisuna Ambrose O   +32 more
core   +1 more source

Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis

Case Reports in Medicine, 2019
The combination of artemether/lumefantrine is indicated for the treatment of acute uncomplicated Plasmodium falciparum malaria. There have been no clinical trials to assess the efficacy of this medication in patients with renal impairment.
Rita Patrocínio-Jesus, João Cunha, Diva Trigo, Bárbara Flor-de-Lima, Patrícia Pacheco   +4 more
doaj   +1 more source

Progression of Malaria in the Human Body, Its Effects on the Liver and Its Various Aspects

Advanced Gut &Microbiome Research, Volume 2026, Issue 1, 2026.
Malaria, an infectious disease caused by Plasmodium parasites, is a significant global health issue, particularly in tropical and subtropical regions. Understanding the development of malaria in the human body and its effects on vital organs like the liver is crucial for effective control and prevention.
Avishek Mandal, Sanmoy Karmakar, Mithun Bhowmick, Sweet Naskar, Ankita Sadhukhan, Arnab Sarkar, Pratibha Bhowmick, Jiong Yu   +7 more
wiley   +1 more source

Pharmaco-epidemiology of artemisinin-based combination therapy in the context of impact evaluation of artemether-lumefantrine on malaria morbidity and mortality during programmatic implementation in rural Tanzania [PDF]

, 2010
In sub-Saharan Africa previous efforts to control malaria have proved less successful mostly due to prolonged use of less efficacious mono-therapy drugs to which Plasmodium falciparum has developed drug resistance.
Kabanywanyi, Abdunoor Mulokozi
core   +1 more source